A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer

Condition:   Breast Neoplasms Interventions:   Drug: Imlunestrant;   Drug: Tamoxifen;   Drug: Anastrozole;   Drug: Letrozole;   Drug: Exemestane Sponsor:   Eli Lilly and Company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials